Advertisement
U.S. markets close in 1 hour 28 minutes

Cidara Therapeutics, Inc. (CDTX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
0.9185+0.0764 (+9.01%)
As of 02:32PM EDT. Market open.
Currency in USD
Earnings EstimateCurrent Qtr. (Dec 2023)Next Qtr. (Mar 2024)Current Year (2023)Next Year (2024)
No. of Analysts3033
Avg. Estimate-0.10-0.31-0.58
Low Estimate-0.160-0.36-0.7
High Estimate-0.070-0.28-0.38
Year Ago EPS-0.190.03-0.43-0.31
Revenue EstimateCurrent Qtr. (Dec 2023)Next Qtr. (Mar 2024)Current Year (2023)Next Year (2024)
No. of Analysts3233
Avg. Estimate11.54M13.05M57.85M21.07M
Low Estimate6.7M11.6M53M5.8M
High Estimate14M14.5M60.3M29.5M
Year Ago Sales10.22M25.99M64.29M57.85M
Sales Growth (year/est)12.90%-49.80%-10.00%-63.60%
Earnings History12/30/20223/30/20236/29/20239/29/2023
EPS Est.-0.17-0.04-0.13-0.16
EPS Actual-0.190.03-0.14-0.09
Difference-0.020.07-0.010.07
Surprise %-11.80%175.00%-7.70%43.80%
EPS TrendCurrent Qtr. (Dec 2023)Next Qtr. (Mar 2024)Current Year (2023)Next Year (2024)
Current Estimate-0.10-0.31-0.58
7 Days Ago-0.1-0.06-0.31-0.58
30 Days Ago-0.1-0.06-0.31-0.58
60 Days Ago-0.1-0.06-0.31-0.58
90 Days Ago-0.1-0.06-0.31-0.58
EPS RevisionsCurrent Qtr. (Dec 2023)Next Qtr. (Mar 2024)Current Year (2023)Next Year (2024)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesCDTXIndustrySector(s)S&P 500
Current Qtr.47.40%N/AN/AN/A
Next Qtr.N/AN/AN/AN/A
Current Year27.90%N/AN/AN/A
Next Year-87.10%N/AN/AN/A
Next 5 Years (per annum)61.20%N/AN/AN/A
Past 5 Years (per annum)N/AN/AN/AN/A